230 related articles for article (PubMed ID: 34296746)
21. Gene expression profiles of beta-adrenergic receptors in canine vascular tumors: a preliminary study.
Clanxet J; Teles M; Hernández-Losa J; Rueda MR; Benitez-Fusté L; Pastor J
BMC Vet Res; 2022 May; 18(1):206. PubMed ID: 35637463
[TBL] [Abstract][Full Text] [Related]
22. Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.
Regan DP; Escaffi A; Coy J; Kurihara J; Dow SW
Vet Comp Oncol; 2017 Dec; 15(4):1309-1322. PubMed ID: 27779362
[TBL] [Abstract][Full Text] [Related]
23. The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression.
Gulay KCM; Aoshima K; Kim S; Kitaguchi R; Kobayashi A; Kimura T
Vet Comp Oncol; 2022 Jun; 20(2):529-534. PubMed ID: 34927338
[TBL] [Abstract][Full Text] [Related]
24. Histiocytic Sarcoma and Hemangiosarcoma Update.
Mullin C; Clifford CA
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):855-879. PubMed ID: 31186126
[TBL] [Abstract][Full Text] [Related]
25. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
[TBL] [Abstract][Full Text] [Related]
26. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
Burton JH; Powers BE; Biller BJ
Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
[TBL] [Abstract][Full Text] [Related]
28. Feline cutaneous hemangiosarcoma: a retrospective study of 18 cases (1998-2003).
McAbee KP; Ludwig LL; Bergman PJ; Newman SJ
J Am Anim Hosp Assoc; 2005; 41(2):110-6. PubMed ID: 15767654
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
Andersen NJ; Nickoloff BJ; Dykema KJ; Boguslawski EA; Krivochenitser RI; Froman RE; Dawes MJ; Baker LH; Thomas DG; Kamstock DA; Kitchell BE; Furge KA; Duesbery NS
Mol Cancer Ther; 2013 Sep; 12(9):1701-14. PubMed ID: 23804705
[TBL] [Abstract][Full Text] [Related]
30. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma.
Locke JE; Barber LG
J Vet Intern Med; 2006; 20(4):962-7. PubMed ID: 16955823
[TBL] [Abstract][Full Text] [Related]
31. Neutering is associated with developing hemangiosarcoma in dogs in the Veterinary Medical Database: An age and time-period matched case-control study (1964-2003).
Robinson KL; Bryan ME; Atkinson ES; Keeler MR; Hahn AW; Bryan JN
Can Vet J; 2020 May; 61(5):499-504. PubMed ID: 32355348
[TBL] [Abstract][Full Text] [Related]
32. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
[TBL] [Abstract][Full Text] [Related]
33. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals.
Schultheiss PC
J Vet Diagn Invest; 2004 Nov; 16(6):522-6. PubMed ID: 15586567
[TBL] [Abstract][Full Text] [Related]
34. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
[TBL] [Abstract][Full Text] [Related]
35. Primary Hemangiosarcoma of the Falciform Fat in Seven Dogs (2007-2015).
Mendez SE; Sykes Crumplar SE; Durham AC
J Am Anim Hosp Assoc; 2020; 56(2):120-126. PubMed ID: 31961215
[No Abstract] [Full Text] [Related]
36. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
[TBL] [Abstract][Full Text] [Related]
37. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
[TBL] [Abstract][Full Text] [Related]
38. Canine, feline, and equine corneal vascular neoplasia: A retrospective study (2007-2015).
Shank AMM; Teixeria LBC; Dubielzig RR
Vet Ophthalmol; 2019 Jan; 22(1):76-87. PubMed ID: 29689619
[TBL] [Abstract][Full Text] [Related]
39. Feline visceral hemangiosarcoma.
Culp WT; Drobatz KJ; Glassman MM; Baez JL; Aronson LR
J Vet Intern Med; 2008; 22(1):148-52. PubMed ID: 18289302
[TBL] [Abstract][Full Text] [Related]
40. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
Pyuen AA; Meuten T; Rose BJ; Thamm DH
PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
